Convergent transcriptomic and connectomic controllers of information integration and its anaesthetic breakdown across mammalian brains.
Summary
Using fMRI across humans and three non-human species, the authors demonstrate that reduced integrated information under anesthesia is a convergent phenomenon linked to regional PVALB/Pvalb gene expression gradients. Brain dynamics become harder to control during disintegration, and thalamic deep brain stimulation reverses both the loss of integration and controllability in macaques.
Key Findings
- Anesthetic-induced breakdown of information integration is conserved across humans, macaques, marmosets, and mice.
- Loss of integration coincides with reduced controllability of brain dynamics and is reversed by thalamic deep brain stimulation in macaques.
- Regional susceptibility aligns with species-specific PVALB/Pvalb gene expression topography; models integrating connectivity and transcriptomics recapitulate these effects.
Clinical Implications
While not directly practice-changing, the identification of PVALB-linked regional susceptibility and the reversibility via thalamic stimulation inform future neuromodulation strategies, monitoring targets, and anesthetic agent development aimed at preserving network integration.
Why It Matters
This work uncovers evolutionarily conserved, transcriptomically anchored controllers of anesthetic-induced breakdown of information integration and demonstrates reversibility with targeted neuromodulation, advancing mechanistic understanding of consciousness under anesthesia.
Limitations
- Single-center prospective cohorts and laboratory settings may limit generalizability to diverse clinical anesthetic contexts
- Indirect translation to clinical outcomes; no randomized clinical trials of monitoring or agent selection are provided
Future Directions
Define patient-level biomarkers (e.g., PVALB-informed EEG signatures) to guide anesthetic dosing, and test neuromodulatory strategies to preserve integration in vulnerable populations.
Study Information
- Study Type
- Cohort
- Research Domain
- Pathophysiology
- Evidence Level
- III - Prospective mechanistic cohorts and animal experiments without randomization
- Study Design
- OTHER